Last update 14 Dec 2024

Anti-CD19 CAR-T (UTC Therapeutics)

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms-
Target
CD19
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesCardiovascular Diseases+ [1]
Active Indication
Multiple Myeloma
Inactive Indication
Acute Myeloid LeukemiaAdult T-Cell Leukemia-LymphomaPre B-cell acute lymphoblastic leukemia
Originator Organization
UTC Therapeutics (Shanghai) Co., Ltd.UTC Therapeutics (Shanghai) Co., Ltd.
Active Organization
UTC Therapeutics (Shanghai) Co., Ltd.UTC Therapeutics (Shanghai) Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Anti-CD19 CAR-T (UTC Therapeutics)
NCT05528887 / RecruitingPhase 1IIT
Safety and Efficacy Study of Chimeric Antigen Receptor T (CAR-T) Cells in the Treatment of Relapsed/Refractory Hematological Malignancies
NCT05513612 / WithdrawnPhase 1IIT
Safety and Efficacy Study of Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies
100 Clinical Results associated with Anti-CD19 CAR-T (UTC Therapeutics)
Login to view more data
100 Translational Medicine associated with Anti-CD19 CAR-T (UTC Therapeutics)
Login to view more data
100 Patents (Medical) associated with Anti-CD19 CAR-T (UTC Therapeutics)
Login to view more data
100 Deals associated with Anti-CD19 CAR-T (UTC Therapeutics)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPhase 1
CN
UTC Therapeutics (Shanghai) Co., Ltd.UTC Therapeutics (Shanghai) Co., Ltd.
01 Aug 2020
Adult T-Cell Leukemia-LymphomaPhase 1
CN
UTC Therapeutics (Shanghai) Co., Ltd.UTC Therapeutics (Shanghai) Co., Ltd.
01 Aug 2020
Multiple MyelomaPhase 1
CN
UTC Therapeutics (Shanghai) Co., Ltd.UTC Therapeutics (Shanghai) Co., Ltd.
01 Aug 2020
Pre B-cell acute lymphoblastic leukemiaPhase 1
CN
UTC Therapeutics (Shanghai) Co., Ltd.UTC Therapeutics (Shanghai) Co., Ltd.
01 Aug 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free